vs

Side-by-side financial comparison of UNIFIRST CORP (UNF) and DENTSPLY SIRONA Inc. (XRAY). Click either name above to swap in a different company.

DENTSPLY SIRONA Inc. is the larger business by last-quarter revenue ($961.0M vs $621.3M, roughly 1.5× UNIFIRST CORP). UNIFIRST CORP runs the higher net margin — 5.5% vs -15.2%, a 20.7% gap on every dollar of revenue. On growth, DENTSPLY SIRONA Inc. posted the faster year-over-year revenue change (6.2% vs 2.7%). DENTSPLY SIRONA Inc. produced more free cash flow last quarter ($60.0M vs $-24.0M). Over the past eight quarters, UNIFIRST CORP's revenue compounded faster (2.3% CAGR vs 0.4%).

UniFirst Corporation is a uniform rental company based in Wilmington, Massachusetts, United States, that manufactures, sells, and rents uniforms and protective clothing. UniFirst employs more than 14,000 people and has over 260 facilities in the United States, Canada, and Europe, including customer service centers, nuclear decontamination facilities, cleanroom locations, distribution centers, and manufacturing plants.

Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.

UNF vs XRAY — Head-to-Head

Bigger by revenue
XRAY
XRAY
1.5× larger
XRAY
$961.0M
$621.3M
UNF
Growing faster (revenue YoY)
XRAY
XRAY
+3.5% gap
XRAY
6.2%
2.7%
UNF
Higher net margin
UNF
UNF
20.7% more per $
UNF
5.5%
-15.2%
XRAY
More free cash flow
XRAY
XRAY
$84.0M more FCF
XRAY
$60.0M
$-24.0M
UNF
Faster 2-yr revenue CAGR
UNF
UNF
Annualised
UNF
2.3%
0.4%
XRAY

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
UNF
UNF
XRAY
XRAY
Revenue
$621.3M
$961.0M
Net Profit
$34.4M
$-146.0M
Gross Margin
36.7%
46.1%
Operating Margin
7.3%
-14.5%
Net Margin
5.5%
-15.2%
Revenue YoY
2.7%
6.2%
Net Profit YoY
-20.3%
66.0%
EPS (diluted)
$1.89
$-0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
UNF
UNF
XRAY
XRAY
Q4 25
$621.3M
$961.0M
Q3 25
$614.4M
$904.0M
Q2 25
$610.8M
$936.0M
Q1 25
$879.0M
Q4 24
$604.9M
$905.0M
Q3 24
$639.9M
$951.0M
Q2 24
$603.3M
$984.0M
Q1 24
$590.7M
$953.0M
Net Profit
UNF
UNF
XRAY
XRAY
Q4 25
$34.4M
$-146.0M
Q3 25
$41.0M
$-427.0M
Q2 25
$39.7M
$-45.0M
Q1 25
$20.0M
Q4 24
$43.1M
$-430.0M
Q3 24
$44.6M
$-494.0M
Q2 24
$38.1M
$-4.0M
Q1 24
$20.5M
$18.0M
Gross Margin
UNF
UNF
XRAY
XRAY
Q4 25
36.7%
46.1%
Q3 25
37.8%
48.8%
Q2 25
36.9%
52.4%
Q1 25
53.0%
Q4 24
37.0%
49.3%
Q3 24
36.1%
52.1%
Q2 24
35.2%
51.9%
Q1 24
32.9%
53.1%
Operating Margin
UNF
UNF
XRAY
XRAY
Q4 25
7.3%
-14.5%
Q3 25
8.1%
-24.1%
Q2 25
7.9%
-13.7%
Q1 25
7.2%
Q4 24
9.2%
-56.2%
Q3 24
8.4%
-48.6%
Q2 24
8.0%
5.1%
Q1 24
4.7%
4.4%
Net Margin
UNF
UNF
XRAY
XRAY
Q4 25
5.5%
-15.2%
Q3 25
6.7%
-47.2%
Q2 25
6.5%
-4.8%
Q1 25
2.3%
Q4 24
7.1%
-47.5%
Q3 24
7.0%
-51.9%
Q2 24
6.3%
-0.4%
Q1 24
3.5%
1.9%
EPS (diluted)
UNF
UNF
XRAY
XRAY
Q4 25
$1.89
$-0.74
Q3 25
$2.23
$-2.14
Q2 25
$2.13
$-0.22
Q1 25
$0.10
Q4 24
$2.31
$-2.09
Q3 24
$2.39
$-2.46
Q2 24
$2.03
$-0.02
Q1 24
$1.09
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
UNF
UNF
XRAY
XRAY
Cash + ST InvestmentsLiquidity on hand
$129.5M
$326.0M
Total DebtLower is stronger
$2.3B
Stockholders' EquityBook value
$2.2B
$1.3B
Total Assets
$2.8B
$5.4B
Debt / EquityLower = less leverage
1.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
UNF
UNF
XRAY
XRAY
Q4 25
$129.5M
$326.0M
Q3 25
$209.2M
$363.0M
Q2 25
$211.9M
$359.0M
Q1 25
$398.0M
Q4 24
$181.0M
$272.0M
Q3 24
$175.1M
$296.0M
Q2 24
$125.4M
$279.0M
Q1 24
$101.9M
$291.0M
Total Debt
UNF
UNF
XRAY
XRAY
Q4 25
$2.3B
Q3 25
Q2 25
Q1 25
Q4 24
$1.7B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
UNF
UNF
XRAY
XRAY
Q4 25
$2.2B
$1.3B
Q3 25
$2.2B
$1.5B
Q2 25
$2.2B
$2.0B
Q1 25
$2.0B
Q4 24
$2.1B
$1.9B
Q3 24
$2.1B
$2.5B
Q2 24
$2.1B
$3.1B
Q1 24
$2.0B
$3.3B
Total Assets
UNF
UNF
XRAY
XRAY
Q4 25
$2.8B
$5.4B
Q3 25
$2.8B
$5.7B
Q2 25
$2.8B
$6.1B
Q1 25
$6.0B
Q4 24
$2.7B
$5.8B
Q3 24
$2.7B
$6.6B
Q2 24
$2.7B
$6.9B
Q1 24
$2.6B
$7.1B
Debt / Equity
UNF
UNF
XRAY
XRAY
Q4 25
1.70×
Q3 25
Q2 25
Q1 25
Q4 24
0.90×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
UNF
UNF
XRAY
XRAY
Operating Cash FlowLast quarter
$14.9M
$101.0M
Free Cash FlowOCF − Capex
$-24.0M
$60.0M
FCF MarginFCF / Revenue
-3.9%
6.2%
Capex IntensityCapex / Revenue
6.3%
4.3%
Cash ConversionOCF / Net Profit
0.43×
TTM Free Cash FlowTrailing 4 quarters
$104.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
UNF
UNF
XRAY
XRAY
Q4 25
$14.9M
$101.0M
Q3 25
$79.0M
Q2 25
$138.4M
$48.0M
Q1 25
$7.0M
Q4 24
$58.1M
$87.0M
Q3 24
$102.3M
$141.0M
Q2 24
$86.3M
$208.0M
Q1 24
$61.1M
$25.0M
Free Cash Flow
UNF
UNF
XRAY
XRAY
Q4 25
$-24.0M
$60.0M
Q3 25
$40.0M
Q2 25
$62.1M
$16.0M
Q1 25
$-12.0M
Q4 24
$24.6M
$36.0M
Q3 24
$63.8M
$98.0M
Q2 24
$37.3M
$156.0M
Q1 24
$27.2M
$-9.0M
FCF Margin
UNF
UNF
XRAY
XRAY
Q4 25
-3.9%
6.2%
Q3 25
4.4%
Q2 25
10.2%
1.7%
Q1 25
-1.4%
Q4 24
4.1%
4.0%
Q3 24
10.0%
10.3%
Q2 24
6.2%
15.9%
Q1 24
4.6%
-0.9%
Capex Intensity
UNF
UNF
XRAY
XRAY
Q4 25
6.3%
4.3%
Q3 25
4.3%
Q2 25
12.5%
3.4%
Q1 25
2.2%
Q4 24
5.5%
5.6%
Q3 24
6.0%
4.5%
Q2 24
8.1%
5.3%
Q1 24
5.7%
3.6%
Cash Conversion
UNF
UNF
XRAY
XRAY
Q4 25
0.43×
Q3 25
Q2 25
3.49×
Q1 25
0.35×
Q4 24
1.35×
Q3 24
2.29×
Q2 24
2.27×
Q1 24
2.98×
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

UNF
UNF

Uniforms And Facility Service Solutions$568.8M92%
First Aid And Safety Solutions$30.8M5%
Other$22.9M4%
Served As An Senior Officer$400.0K0%

XRAY
XRAY

Essential Dental Solutions$372.0M39%
Equipment And Instruments$160.0M17%
Implants And Prosthetics$150.0M16%
CADCAM$139.0M14%
Wellspect Healthcare$88.0M9%
Orthodontics$52.0M5%

Related Comparisons